Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$80K Buy
665
+5
+0.8% +$577 0.1% 72
2025
Q4
$69.5K Buy
660
+5
+0.8% +$469 0.08% 80
2025
Q3
$55K Buy
+655
New +$53.9K 0.07% 89
2025
Q2
Sell
-704
Closed -$63.2K 175
2025
Q1
$63.2K Buy
704
+5
+0.7% +$467 0.09% 79
2024
Q4
$69.5K Buy
699
+5
+0.7% +$515 0.1% 80
2024
Q3
$78.8K Buy
694
+4
+0.6% +$475 0.12% 77
2024
Q2
$85.4K Buy
690
+72
+12% +$9.27K 0.13% 73
2024
Q1
$81.6K Buy
618
+3
+0.5% +$370 0.13% 76
2023
Q4
$67K Buy
+615
New +$63.8K 0.11% 75

Other funds holding MRK

Wiser Advisor Group's MRK Position: Q1 2026 in Review

Wiser Advisor Group increased its Merck (MRK) stake by 0.76% in Q1 2026, buying an estimated $577 and bringing the position to 665 shares worth $80K. The position accounts for 0.1% of the portfolio, ranked #72.

Wiser Advisor Group first reported a position in MRK in Q4 2023 and has held it in 9 quarters since. The position peaked at $85.4K in Q2 2024. 3,774 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Wiser Advisor Group held 665 shares of Merck worth $80K as of Q1 2026.
  • Wiser Advisor Group bought 5 Merck shares in Q1 2026, an estimated $577.
  • Merck made up 0.1% of Wiser Advisor Group's portfolio in Q1 2026, its #72 holding.
  • Wiser Advisor Group first reported a position in Merck in Q4 2023 and has held it in 9 quarters since.
  • Wiser Advisor Group's Merck position peaked at $85.4K in Q2 2024.
  • 3,774 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Wiser Advisor Group's 13F filing for Q1 2026, filed 22 Apr 2026.